Moderna Inc. has asked U.S. regulators to authorize a new version of its Covid-19 vaccine that targets the latest coronavirus strains.
Moderna said on Tuesday that it is ready to ship doses of the new shot in September if it is cleared by the Food and Drug Administration. Health authorities have been seeking such boosters for a campaign to bolster the immune defenses of people during the fall and winter.